Search research articles
Contact Us
Filters
Showing results (61-70 of 137) with videos related to
Page
of 14
Sort By:
Cancer
|
September 1, 1986
Treatment for unresectable hepatoma via selective hepatic arterial infusion of lymphokine-activated killer cells generated from autologous spleen cells
K Okuno, H Takagi, T Nakamura, et al.
Nihon Gan Chiryo Gakkai Shi
|
October 20, 1985
[Induction of lymphokine-activated killer (LAK) cells from tumor-bearer splenocytes and their utilization in inhibition of tumor metastasis]
K Okuno, T Nakamura, H Takagi, et al.
Japanese Heart Journal
|
November 1, 1985
Myocardial involvement in the Marfan syndrome
Y Fujiseki, K Okuno, M Tanaka, et al.
Molecular Biotherapy
|
June 1, 1992
Augmentation of human lymphokine-activated killer cell activity in splenic lymphocytes by the combination of low-dose interleukin 2 plus interleukin 3
K Okuno, H Ohnishi, Y Shilayama, et al.
Journal of the American College of Surgeons
|
June 1, 1997
Lymph node metastases detected in the mesorectum distal to carcinoma of the rectum by the clearing method: justification of total mesorectal excision
J Hida, M Yasutomi, T Maruyama, et al.
Biotherapy (Dordrecht, Netherlands)
|
January 1, 1992
Clinical trials of intrasplenic arterial infusion of interleukin-2 (IS-IL-2) to patients with advanced cancer
K Okuno, H Ohnishi, K Koh, et al.
Nihon Geka Gakkai Zasshi
|
April 1, 1991
[Successful liver metastasis model with neuraminidase treated colon 26 adenocarcinoma via portal vein: preliminary report]
Y Shilayama, K Okuno, H Ohnishi, et al.
Journal of the American College of Surgeons
|
May 1, 1997
Does lateral lymph node dissection improve survival in rectal carcinoma? Examination of node metastases by the clearing method
J Hida, M Yasutomi, K Fujimoto, et al.
Princess Takamatsu Symposia
|
January 1, 1988
Requirements for T cell recognition and elimination of retrovirally-transformed cells
P Greenberg, J Klarnet, D Kern, et al.
Nihon Geka Gakkai Zasshi
|
July 1, 1987
[Injection of interleukin-2 (IL-2) into the tumor-bearer's spleen augments lymphokine-activated killer (LAK) activity in vitro and inhibits tumor metastasis]
K Okuno, H Ohnishi, H Takagi, et al.
Page
of 14
Search research articles
Search
Showing results (61-70 of 137) with videos related to
Sort By:
Page
of 14
Cancer
|
September 1, 1986
Treatment for unresectable hepatoma via selective hepatic arterial infusion of lymphokine-activated killer cells generated from autologous spleen cells
K Okuno, H Takagi, T Nakamura, et al.
Nihon Gan Chiryo Gakkai Shi
|
October 20, 1985
[Induction of lymphokine-activated killer (LAK) cells from tumor-bearer splenocytes and their utilization in inhibition of tumor metastasis]
K Okuno, T Nakamura, H Takagi, et al.
Japanese Heart Journal
|
November 1, 1985
Myocardial involvement in the Marfan syndrome
Y Fujiseki, K Okuno, M Tanaka, et al.
Molecular Biotherapy
|
June 1, 1992
Augmentation of human lymphokine-activated killer cell activity in splenic lymphocytes by the combination of low-dose interleukin 2 plus interleukin 3
K Okuno, H Ohnishi, Y Shilayama, et al.
Journal of the American College of Surgeons
|
June 1, 1997
Lymph node metastases detected in the mesorectum distal to carcinoma of the rectum by the clearing method: justification of total mesorectal excision
J Hida, M Yasutomi, T Maruyama, et al.
Biotherapy (Dordrecht, Netherlands)
|
January 1, 1992
Clinical trials of intrasplenic arterial infusion of interleukin-2 (IS-IL-2) to patients with advanced cancer
K Okuno, H Ohnishi, K Koh, et al.
Nihon Geka Gakkai Zasshi
|
April 1, 1991
[Successful liver metastasis model with neuraminidase treated colon 26 adenocarcinoma via portal vein: preliminary report]
Y Shilayama, K Okuno, H Ohnishi, et al.
Journal of the American College of Surgeons
|
May 1, 1997
Does lateral lymph node dissection improve survival in rectal carcinoma? Examination of node metastases by the clearing method
J Hida, M Yasutomi, K Fujimoto, et al.
Princess Takamatsu Symposia
|
January 1, 1988
Requirements for T cell recognition and elimination of retrovirally-transformed cells
P Greenberg, J Klarnet, D Kern, et al.
Nihon Geka Gakkai Zasshi
|
July 1, 1987
[Injection of interleukin-2 (IL-2) into the tumor-bearer's spleen augments lymphokine-activated killer (LAK) activity in vitro and inhibits tumor metastasis]
K Okuno, H Ohnishi, H Takagi, et al.
Page
of 14